BioSpace News Archive

Deals

Menarini Group to Acquire Stemline Therapeutics in Transaction Valued at Up to $677 Million

Menarini will support further development of Stemline’s ELZONRIS® and enable global expansion by leveraging its commercial infrastructure in Europe and other ex-U.S. geographies

May 4, 2020
·
12 min read
Business

HOOKIPA Pharma To Report First Quarter 2020 Financial Results on May 14, 2020

HOOKIPA Pharma Inc., a company developing a new class of immunotherapeutics targeting infectious diseases and cancers based on its proprietary arenavirus platform, announced that it will release financial results for the first quarter ended March 31, 2020 before the market opens on Thursday, May 14, 2020.

May 4, 2020
·
4 min read
BioMidwest

Meridian Supports Illinois Communities in Need During the COVID-19 Pandemic

Due to the COVID-19 pandemic, people across Illinois are facing challenges that extend beyond medical care.

May 4, 2020
·
3 min read
Biotech Beach

Oncolytics Biotech® to Present Clinical Findings of Pelareorep-Induced Immune Response in Breast Tumors at the ESMO Breast Cancer Virtual Meeting

AWARE-1 data demonstrate pelareorep-mediated priming of an adaptive immune response

May 4, 2020
·
7 min read
Deals

Centene To Invest In Critical Mental Health Resources

Centene partners with organizations across the country to support their respective mental health efforts during COVID-19 pandemic

May 4, 2020
·
12 min read
BioMidwest

American Society For Artificial Internal Organs (ASAIO) Outlines Best Practices For Advanced Pulmonary And Cardiac Support Of COVID-19 Patients

A Living Working Document, Co-Authored by University of Arizona Regents’ Professor & ASAIO President Marvin J. Slepian, MD, Published in ASAIO Journal & Circulation: Heart Failure

May 4, 2020
·
5 min read
Alkermes Launches COVID-19 Relief Fund to Support Innovative Programs Helping Vulnerable Patient Communities

Special Edition of Alkermes Inspiration Grants® Program Designed to Support COVID-19-Related Needs of People Affected by Addiction, Serious Mental Illness or Cancer

May 4, 2020
·
3 min read
Business

Protagonist Therapeutics to Announce First Quarter 2020 Financial Results and Provide Corporate and R&D Update

Protagonist Therapeutics, Inc. will announce first quarter financial results after the NASDAQ market closes on Thursday, May 7, 2020.

May 4, 2020
·
2 min read
Biotech Bay

Nevro To Participate in Upcoming May 2020 Conferences

Nevro Corp., a global medical device company that is providing innovative, evidence-based solutions for the treatment of chronic pain, announced that Nevro Chairman, CEO and President D. Keith Grossman is scheduled to speak at the following upcoming virtual investor conferences:.

May 4, 2020
·
1 min read
BioForest

University of Oxford and Sound Pharmaceuticals complete Phase 2 Bipolar Disorder Study with SPI-1005

The University of Oxford and Sound Pharmaceuticals, are pleased to announce the successful completion of a Phase 2a study testing SPI-1005 as a new treatment for bipolar disorder.

May 4, 2020
·
3 min read